You went in for headaches, or dizziness, or because a physical turned up something worth checking. The MRI was, in the words of whoever called you, “basically fine.” Then you read the report yourself and found a sentence like this:
Scattered T2/FLAIR hyperintensities within the periventricular and subcortical white matter, likely representing chronic microvascular ischemic changes.
Nobody explained it. You searched the phrase. Within about ninety seconds you found the word dementia, and the rest of your week was affected.
This is one of the most common reasons people come to see me, and one of the most frequently mishandled findings in all of medicine — not because the finding is dangerous, but because it is delivered without interpretation.
The Short Answer
White matter hyperintensities are not a diagnosis of dementia, and they are not evidence that you have Alzheimer’s disease. They are extremely common — present in the majority of people over 60 and in many healthy adults in their forties and fifties.
What they represent is the imaging signature of small blood vessel change in the brain. In small amounts, they are an ordinary feature of aging with limited clinical significance. In larger amounts, they are a meaningful marker of vascular risk that is associated with stroke, cognitive decline, gait problems, and depression.
Here is the part that matters most, and that almost nobody is told: their progression is modifiable. We have randomized trial evidence that treating blood pressure aggressively slows their accumulation. That makes this one of the few findings in cognitive neurology where you can directly alter the trajectory.
What Are White Matter Hyperintensities?
The brain’s white matter is the wiring — the myelinated axons that connect regions to one another. On certain MRI sequences, specifically T2-weighted and FLAIR images, areas of damaged or altered white matter appear bright against the surrounding tissue. Those bright areas are the hyperintensities.
The underlying change is usually chronic reduction in perfusion through the brain’s smallest arterioles, along with breakdown of the blood-brain barrier and leakage of fluid into surrounding tissue. Over years, this produces demyelination and loss of axons in the affected regions. This is the most common manifestation of cerebral small vessel disease.
The functional consequence, when there is one, follows from what white matter does. It is connection. Damage to connections tends to slow things down rather than erase them — which is why the cognitive signature of significant white matter disease is reduced processing speed and impaired executive function, not the dense memory loss characteristic of Alzheimer’s disease. Patients describe themselves as slower, less sharp, and less able to switch between tasks, rather than as forgetting events entirely.
Decoding the Language in Your Report
Radiologists use several phrases for the same finding, and the variation frightens people unnecessarily. These all describe white matter hyperintensities:
- Chronic microvascular ischemic changes — the most common phrasing, and the most alarming to read. “Ischemic” makes people think stroke; here it refers to chronic low perfusion in small vessels, not an acute event.
- Chronic small vessel ischemic disease — the same finding.
- Leukoaraiosis — an older term meaning, roughly, white matter rarefaction.
- Nonspecific T2/FLAIR hyperintensities — used when the radiologist cannot determine the cause from imaging alone, which is common when the burden is small.
- Periventricular and deep white matter hyperintensities — describes location; these two distributions are often graded separately.
Two qualifiers in your report carry real information. Words like scattered, punctate, few, or minimal indicate a low burden. Words like confluent, extensive, advanced, or beyond that expected for age indicate meaningful burden that deserves evaluation.
The single most useful phrase to look for is a comparison to age. “Within normal limits for age” and “advanced for age” are different findings requiring different responses, and the report will often say which.
How Common Are They?
Common enough that their presence alone tells you very little.
Some degree of white matter hyperintensity is found in the majority of people over 60, and by the eighties they are nearly universal. A few punctate foci in a healthy 50-year-old — particularly someone with migraine — is an ordinary finding. Population imaging studies routinely find them in people with entirely normal cognition and no symptoms.
This is why the presence or absence of hyperintensities is the wrong question. The questions that matter are how much, where, how does it compare to your age, and is it increasing.
How Much Is Too Much? The Fazekas Scale
Radiologists commonly grade burden using the Fazekas scale, which rates periventricular and deep white matter separately from 0 to 3. If your report mentions a Fazekas grade, this is what it means:
- Grade 0: None.
- Grade 1: Punctate foci or a thin periventricular rim. Very common, generally of limited clinical significance, and typical for middle age and beyond.
- Grade 2: Beginning confluence of lesions. This is where burden starts to become clinically relevant and where evaluation of vascular risk factors is clearly warranted.
- Grade 3: Large confluent areas. Consistently associated with cognitive, gait, and stroke risk, and warranting thorough evaluation and aggressive risk management.
Most reports do not include a Fazekas grade. If yours does not and the descriptive language is ambiguous, it is reasonable to ask for the images to be reviewed with the grading in mind — the distinction between grade 1 and grade 2 genuinely changes how I manage a patient.
What Causes White Matter Hyperintensities?
In order of impact:
- Hypertension. By a wide margin the most important, and the most modifiable. Blood pressure elevation over years is the dominant driver of small vessel change. Nighttime blood pressure — which standard office measurement never captures — appears particularly relevant.
- Age. Non-modifiable and expected.
- Diabetes and insulin resistance. Including the pre-diabetic range that standard screening often lets pass.
- Smoking.
- Obstructive sleep apnea. Repeated nocturnal oxygen desaturation and blood pressure surges, frequently undiagnosed.
- Atrial fibrillation and other cardiac disease.
- Chronic kidney disease. The kidney and the brain share small vessel architecture; disease in one often reflects disease in the other.
- Dyslipidemia, and elevated homocysteine.
- Migraine, especially with aura. Associated with white matter lesions that are typically small, deep, and — importantly — not generally associated with cognitive decline. This is a frequent source of unnecessary alarm in younger patients.
In women, there is an additional association worth noting: research measuring hot flashes objectively has found a relationship between vasomotor symptom burden, particularly at night, and greater white matter hyperintensity volume. See Perimenopause, Menopause, and Memory Loss.
What Do They Actually Predict?
I want to give you the real numbers rather than either reassurance or alarm, because both are available online and neither is honest on its own.
Meta-analyses of population studies have found that a high burden of white matter hyperintensities is associated with roughly a doubling of dementia risk and approximately a tripling of stroke risk, along with increased risk of cognitive decline, gait disturbance and falls, and late-life depression.
Now the essential context. Those figures apply to high burden — confluent disease, Fazekas 2 to 3 — not to the punctate foci that appear on most middle-aged scans. They are relative risks derived from populations, not individual predictions. They describe associations in observational cohorts, where white matter burden travels alongside the vascular risk factors that caused it. And a doubling of a modest absolute risk remains a modest absolute risk.
What the finding genuinely tells you is that your small vessels have been under strain, usually for years, and that this is measurable. That is worth acting on — and it is a far more useful frame than a probability of dementia.
When It Is Not Ordinary Small Vessel Disease
Most white matter hyperintensities are vascular and age-related. A minority reflect something else, and the pattern usually distinguishes them.
Multiple sclerosis
MS lesions have a characteristic appearance: ovoid, oriented perpendicular to the ventricles, often involving the corpus callosum, juxtacortical regions, and brainstem or spinal cord. The distribution differs meaningfully from vascular disease, and radiologists generally distinguish them. Age, symptoms, and lesion pattern together usually make this clear.
Cerebral amyloid angiopathy
Amyloid deposits in the walls of cortical vessels rather than in brain tissue. It produces a posterior-predominant pattern of white matter change, lobar microbleeds, and sometimes cortical superficial siderosis, and it carries a risk of lobar hemorrhage. It is relevant to anti-amyloid therapy decisions because it substantially affects the safety profile of those drugs. Detecting it requires susceptibility-weighted or gradient-echo sequences, which are not always included in a routine brain MRI — worth confirming if the question arises.
CADASIL and other genetic small vessel diseases
CADASIL is a hereditary small vessel disease caused by NOTCH3 mutations. Suspect it when there is extensive white matter disease in a person under 55, migraine with aura, a family history of stroke or early dementia, and characteristic involvement of the anterior temporal poles and external capsules. It is rare, but it is the diagnosis that gets missed for years.
Other causes
Prior infection, inflammatory and autoimmune conditions, vasculitis, radiation exposure, and certain metabolic conditions can all produce white matter signal change. A pattern that does not fit ordinary small vessel disease deserves a neurologist’s read of the actual images rather than the report alone.
What Evaluation Should Follow
If the burden is more than minimal, or is described as advanced for age, the following is a reasonable workup — and most of it is ordinary testing that simply needs to be ordered:
- Blood pressure assessed properly, which means ambulatory or home monitoring rather than a single office reading. Nocturnal pattern matters; people whose blood pressure fails to fall overnight carry higher small vessel risk, and this is invisible without 24-hour monitoring.
- Hemoglobin A1c and fasting insulin, to detect insulin resistance before glucose becomes abnormal.
- Full lipid panel including ApoB and Lp(a). Lp(a) is genetically determined, measured once, and routinely omitted despite being a meaningful vascular risk factor.
- Kidney function, including eGFR and urine albumin-to-creatinine ratio.
- Homocysteine, B12, and folate.
- A sleep study if there is any suggestion of sleep apnea — snoring, unrefreshing sleep, nocturnal awakening, morning headache, or resistant hypertension.
- Cardiac rhythm assessment, with extended monitoring where atrial fibrillation is plausible.
- Formal cognitive testing to establish a baseline, with particular attention to processing speed and executive function, which are the domains white matter disease affects first.
- Review of the actual images, not only the report, including susceptibility-weighted sequences to assess for microbleeds.
If cognitive symptoms are present alongside significant white matter burden, it is also reasonable to assess whether Alzheimer’s pathology is contributing, since mixed vascular and Alzheimer’s pathology is the rule rather than the exception in cognitive decline. See My p-tau217 Blood Test Is Positive. Do I Have Alzheimer’s?
Can You Stop Them from Getting Worse?
Yes — and this is the most important and least communicated fact about this finding.
The SPRINT MIND trial randomized adults with hypertension to intensive blood pressure control targeting a systolic below 120 versus a standard target below 140. An MRI substudy published in JAMA in 2019 found that participants in the intensive treatment group had significantly less accumulation of white matter hyperintensity volume over the study period than those treated to the standard target.
That is randomized evidence that a routinely available intervention slows the progression of this specific imaging finding. Very little in cognitive neurology meets that standard.
Existing lesions do not reverse. But the trajectory from here is genuinely open, and the interventions are the ones you would expect: blood pressure to target with attention to nighttime control, treatment of sleep apnea, glycemic and metabolic management, lipid management, smoking cessation, regular aerobic exercise, sodium reduction, alcohol moderation, and anticoagulation where atrial fibrillation is present.
For the broader framework, see The 40%: What Modifiable Risk Factors Mean for Dementia Prevention.
What This Finding Does Not Mean
It does not mean you have had strokes. “Ischemic changes” describes chronic small vessel change, not a history of acute stroke. A completed stroke looks different on imaging and is reported differently.
It does not mean you have dementia or Alzheimer’s disease. Dementia is a clinical diagnosis requiring cognitive impairment that interferes with independent function. Imaging alone cannot establish it, and white matter hyperintensities are not markers of Alzheimer’s pathology.
It does not mean decline is coming. Most people with mild to moderate burden remain cognitively normal. Burden matters, trajectory matters more, and trajectory is partly under your control.
It does not mean nothing can be done. The opposite is true, and this is the reason the finding is worth having rather than worth fearing. Unlike most findings in this field, this one comes with a randomized trial showing what changes it.
Common Questions
Are white matter hyperintensities the same as dementia?
No. They are an MRI finding indicating small blood vessel change in the brain. Dementia is a clinical diagnosis based on cognitive impairment that interferes with daily function. Most people with white matter hyperintensities do not have dementia and never develop it.
What does “chronic microvascular ischemic changes” mean on an MRI report?
It is the standard radiology phrase for white matter hyperintensities. It describes chronic change in the brain’s smallest blood vessels, not an acute stroke. It is one of the most common findings on brain MRI in adults over 50.
Are a few white matter hyperintensities normal at 50?
Generally yes. Scattered punctate foci are common in healthy adults in their forties and fifties, particularly in people with migraine, and are usually of limited clinical significance. What warrants evaluation is confluent burden or burden described as advanced for age.
Can white matter hyperintensities go away?
Established lesions do not typically reverse. Progression, however, can be slowed — randomized trial evidence shows that intensive blood pressure control reduces the rate at which new white matter hyperintensity volume accumulates.
Do white matter hyperintensities cause memory loss?
High burden is associated with cognitive decline, but the pattern differs from Alzheimer’s disease. White matter disease primarily slows processing speed and impairs executive function — planning, multitasking, mental flexibility — rather than causing the dense loss of recent memory typical of Alzheimer’s.
What is the Fazekas scale?
A grading system rating white matter hyperintensity burden from 0 to 3, applied separately to periventricular and deep white matter. Grade 1 indicates punctate foci and is common and generally benign; grades 2 and 3 indicate early confluent and confluent disease and are more clinically significant.
Should I see a neurologist for white matter hyperintensities?
It is worthwhile if the burden is described as moderate, confluent, or advanced for age, if you are under 55 with significant burden, if there are cognitive or gait symptoms, or if the pattern is atypical. Minimal findings in an older adult with well-controlled vascular risk factors often need risk factor management rather than specialty referral.
The Bottom Line
A radiology report is written for the referring physician, not for you, and “chronic microvascular ischemic changes” is a phrase that causes far more fear than the finding usually warrants.
What you have is a measurement of how your small blood vessels have fared, rendered visible. If the burden is minimal, it is information for your baseline. If it is significant, it is an early and unusually actionable warning — the kind of finding that, addressed in your fifties rather than discovered in your seventies, changes what the next twenty years look like.
The patients who do best with this finding are the ones who stop asking whether it means dementia and start asking what their nighttime blood pressure is.
Dr. Nadir Bilici is a double board-certified neurologist and lifestyle medicine physician specializing in preventive neurology, Alzheimer’s prevention, and cognitive risk assessment. He sees patients via telehealth nationwide and in person in New York City.
This article is for educational purposes and does not constitute medical advice. Imaging findings should be interpreted by a qualified clinician in the context of your symptoms and history.
Published October 2026 · Medically reviewed by Nadir Bilici, MD, DipIBLM. See our editorial policy.